# The Influence of Sequential Tau Protein and Amyloid Plaque Imaging Changes on Stroke Prognosis and Cognitive Outcome

> **NCT04572477** · PHASE2 · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Post-stroke Dementia, Vascular Mild Cognitive Impairment

## Interventions

- **DRUG:** [18F]THK-5351
- **DRUG:** [18F]AV-45

## Key facts

- **NCT ID:** NCT04572477
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-01
- **Primary completion:** 2023-11-30
- **Final completion:** 2024-05-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04572477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04572477, "The Influence of Sequential Tau Protein and Amyloid Plaque Imaging Changes on Stroke Prognosis and Cognitive Outcome". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT04572477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*